Isabel Bejm, PharmD

Student
MCPHS

Poster(s):

• (47) Payer policies and access restrictions for CRISPR-based gene therapy in sickle cell disease and beta-thalassemia: A systematic review of U.S. coverage frameworks
  Wednesday, October 29, 2025